LAMIVUDINE AND ZIDOVUDINE - LAMIVUDINE AND ZIDOVUDINE
Navigation: NDC > Supplier starting with: L > LUPIN PHARMACEUTICALS, INC.| Field | Value |
|---|---|
| NDC Code: | 68180-284 |
| Proprietary Name: | LAMIVUDINE AND ZIDOVUDINE |
| Suffix: | |
| Non-Proprietary Name: | LAMIVUDINE AND ZIDOVUDINE |
| Dosage Form: | TABLET |
| Method: | ORAL |
| Original Marketing Date: | 14-05-2012 |
| Category Name: | ANDA |
| Application Number: | ANDA090246 |
| Labeler: | LUPIN PHARMACEUTICALS, INC. |
| Substance Name: | LAMIVUDINE; ZIDOVUDINE |
| Active Numerator Strength: | 150; 300 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| DEA Schedule: |